Enterobacter cloacae
| Enterobacter cloacae | |
|---|---|
| Enterobacter cloacae on tryptic soy agar. | |
| Scientific classification | |
| Kingdom: | Bacteria |
| Phylum: | Proteobacteria |
| Class: | Gamma Proteobacteria |
| Order: | Enterobacteriales |
| Family: | Enterobacteriaceae |
| Genus: | Enterobacter |
| Binomial name | |
|
Enterobacter cloacae (Jordan 1890) Hormaeche and Edwards 1960 |
|
| Subspecies | |
|
E. c. subsp. cloacae |
|
| Synonyms | |
|
Bacillus cloacae Jordan 1890 |
|
Enterobacter cloacae is a clinically significant Gram-negative, facultatively-anaerobic, rod-shaped bacterium.
Microbiology
- BioHazard Level: 1 (level 2 in Canada)
- Growth Temperature: 30°C
Appropriate growth media:nutrient agar, nutrient broth
- Genomic sources for restriction enzymes (at this website):
Ecl136II, EclHKI, EclXI
- Gram Stain: Negative
- Respiration:Facultatively anaerobic
- Motility: Peritrichous flagella
- Taxonomy:
Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacteriales; Enterobacteriaceae; Enterobacter
- Industrial implications:
Enterobacter cloacae has been used in a bioreactor based method for the biodegradation of explosives and in the biological control of plant diseases.
- Misc.:
Enterobacter cloacae is a rod-shaped bacterium that is oxidase-negative and catalase-positive.
Clinical significance
Enterobacter cloacae is sometimes associated with urinary tract and respiratory tract infections. Treatment with cefepime and gentamicin has been reported.[1]
See also
References
- ^ Barnes BJ, Wiederhold NP, Micek ST, Polish LB, Ritchie DJ (April 2003). "Enterobacter cloacae ventriculitis successfully treated with cefepime and gentamicin: case report and review of the literature". Pharmacotherapy 23 (4): 537–42. doi:10.1592/phco.23.4.537.32126. PMID 12680484.
| This Proteobacteria-related article is a stub. You can help Wikipedia by expanding it. |